Skip to main content
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1996;4(5):281–286. doi: 10.1155/S1064744996000543

Screening for Human Immunodeficiency Virus in Inner City Females With Abnormal Cervical Cytology

T Scott Jennings 1,2,✉, Peter Dottino 1, Rhoda Sperling 1, Ann Marie Beddoe 1
PMCID: PMC2364508  PMID: 18476108

Abstract

Objective: This report evaluates the acceptance, results, and predictors of human immunodeficiency virus (HIV) infection in inner city women referred to a colposcopy clinic for abnormal cervical cytology.

Methods: HIV testing results of 1,908 inner city women referred for abnormal cervical cytology were analyzed retrospectively with respect to acceptance, race, ethnicity, Pap smear results, sexually transmitted diseases (STDs), HIV exposures, and final histologic findings.

Results: HIV testing was accepted by 50.4% of patients. Women who agreed to screening were significantly more likely to admit exposure to HIV or to be Hispanic, foreign-born, or have a history of multiple STDs. Of those screened, 3.3% were found to be HIV seropositive. Although higher grades of referral Pap smears were noted in the women found to be HIV seropositive, final histologic findings were not different. The only predictors of unknown HIV seropositivity were admitted HIV exposure and external condyloma.

Conclusions: Fifty percent of inner city women of unknown HIV status referred for abnormal cervical cytology will accept HIV serotesting and 3.3% are found to be positive. Most HIV-seropositive women can be detected based on either a history of exposure to HIV or the presence of external condyloma.

Full Text

The Full Text of this article is available as a PDF (512.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Caussy D., Goedert J. J., Palefsky J., Gonzales J., Rabkin C. S., DiGioia R. A., Sanchez W. C., Grossman R. J., Colclough G., Wiktor S. Z. Interaction of human immunodeficiency and papilloma viruses: association with anal epithelial abnormality in homosexual men. Int J Cancer. 1990 Aug 15;46(2):214–219. doi: 10.1002/ijc.2910460212. [DOI] [PubMed] [Google Scholar]
  2. Dottino P. R., Sperling R., Kee R. Screening for human immunodeficiency virus and sexually transmitted diseases in an inner-city colposcopy clinic. Mt Sinai J Med. 1993 Sep;60(4):327–329. [PubMed] [Google Scholar]
  3. Laga M., Icenogle J. P., Marsella R., Manoka A. T., Nzila N., Ryder R. W., Vermund S. H., Heyward W. L., Nelson A., Reeves W. C. Genital papillomavirus infection and cervical dysplasia--opportunistic complications of HIV infection. Int J Cancer. 1992 Jan 2;50(1):45–48. doi: 10.1002/ijc.2910500110. [DOI] [PubMed] [Google Scholar]
  4. Lo B., Steinbrook R. L., Cooke M., Coates T. J., Walters E. J., Hulley S. B. Voluntary screening for human immunodeficiency virus (HIV) infection. Weighing the benefits and harms. Ann Intern Med. 1989 May 1;110(9):727–733. doi: 10.7326/0003-4819-110-9-727. [DOI] [PubMed] [Google Scholar]
  5. Maiman M., Fruchter R. G., Guy L., Cuthill S., Levine P., Serur E. Human immunodeficiency virus infection and invasive cervical carcinoma. Cancer. 1993 Jan 15;71(2):402–406. doi: 10.1002/1097-0142(19930115)71:2<402::aid-cncr2820710222>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  6. Maiman M., Fruchter R. G., Serur E., Boyce J. G. Prevalence of human immunodeficiency virus in a colposcopy clinic. JAMA. 1988 Oct 21;260(15):2214–2215. [PubMed] [Google Scholar]
  7. Mandelblatt J. S., Fahs M., Garibaldi K., Senie R. T., Peterson H. B. Association between HIV infection and cervical neoplasia: implications for clinical care of women at risk for both conditions. AIDS. 1992 Feb;6(2):173–178. [PubMed] [Google Scholar]
  8. McCarthy K. H., Johnson M. A., Lawton F. G., Studd J. W. Acceptability of screening for HIV seroprevalence in women with cervical pathology. Lancet. 1992 Oct 24;340(8826):1040–1041. doi: 10.1016/0140-6736(92)93056-s. [DOI] [PubMed] [Google Scholar]
  9. McKenna M. T., Buehler J. W., Qualters J. R., Chu S. Y. HIV and trends in cervical cancer death rates among young women. Am J Public Health. 1993 Dec;83(12):1792–1793. doi: 10.2105/ajph.83.12.1792-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rotkin I. D. A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res. 1973 Jun;33(6):1353–1367. [PubMed] [Google Scholar]
  11. Schwartz L. B., Carcangiu M. L., Bradham L., Schwartz P. E. Rapidly progressive squamous cell carcinoma of the cervix coexisting with human immunodeficiency virus infection: clinical opinion. Gynecol Oncol. 1991 Jun;41(3):255–258. doi: 10.1016/0090-8258(91)90319-z. [DOI] [PubMed] [Google Scholar]
  12. Smith J. R., Kitchen V. S., Botcherby M., Hepburn M., Wells C., Gor D., Forster S. M., Harris J. R., Steer P., Mason P. Is HIV infection associated with an increase in the prevalence of cervical neoplasia? Br J Obstet Gynaecol. 1993 Feb;100(2):149–153. doi: 10.1111/j.1471-0528.1993.tb15211.x. [DOI] [PubMed] [Google Scholar]
  13. Spitzer M., Brennessel D., Seltzer V. L., Silver L., Lox M. S. Is human papillomavirus-related disease an independent risk factor for human immunodeficiency virus infection? Gynecol Oncol. 1993 May;49(2):243–246. doi: 10.1006/gyno.1993.1115. [DOI] [PubMed] [Google Scholar]
  14. Whyte H. E., Fitzhardinge P. M., Shennan A. T., Lennox K., Smith L., Lacy J. Extreme immaturity: outcome of 568 pregnancies of 23-26 weeks' gestation. Obstet Gynecol. 1993 Jul;82(1):1–7. [PubMed] [Google Scholar]
  15. ter Meulen J., Eberhardt H. C., Luande J., Mgaya H. N., Chang-Claude J., Mtiro H., Mhina M., Kashaija P., Ockert S., Yu X. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa. Int J Cancer. 1992 Jun 19;51(4):515–521. doi: 10.1002/ijc.2910510403. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES